最新ニュース Stepan (NYSE:SCL) 株価情報

Stepan

Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. The majority of Stepan's revenue comes from the United States, followed by France, Poland, the United Kingdom, Brazil, Mexico, and other countries.

Stepan Co

Suncliff Inc

SEARCHLIGHT RES INC by Searchlight Resources Inc.

Searchlight Resources Inc

Scilex Holding Co

Northern Lights Fund Trust III Swan Enhanced Dividend Income ETF

Scales Corp Ltd

Stepan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) reported quarterly earnings of $0.84 per share which beat the analyst consensus estimate of $0.64 by 31.25 percent. This is a 31.25 percent increase over earnings of $0.64 per share from the same period last year. The company reported quarterly sales of $593.25 million which beat the analyst consensus estimate of $558.00 million by 6.32 percent. This is a 7.59 percent increase over sales of $551.42 million the same period last year.

Earnings

Earnings Beats

News

Stepan Q1 Adj. EPS $0.84 Beats $0.64 Estimate, Sales $593.25M Beat $558.00M Estimate

ACGL

AEYE

AMSF

APAM

ARCB

ARCC

ASTE

ASTL

ATRC

BBIO

BBVA

BGFV

BKNG

BRSP

CECO

CHCT

CLVT

CSGP

CVLT

DHIL

ENSG

ENVA

ESRT

ETWO

EXLS

FELE

FFIC

FIBK

FICO

FOUR

FRSH

FRST

FSLR

FYBR

HLMN

HOUS

HRZN

HSBC

HURN

ILPT

INCY

INTZ

JAKK

JBGS

JBLU

KNSA

LFUS

LGIH

Laboratory Corporation Of America Holdings

LOGI

LXFR

Earnings Scheduled For April 29, 2025

Stepan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) is preparing to release its quarterly earnings on Tuesday, 2025-04-29. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect Stepan to report an earnings per share (EPS) of $0.60.
Anticipation surrounds Stepan's announcement, with investors hoping to hear about both surpassing estimates and receiving positive guidance for the next quarter.
New investors should understand that while earnings performance is important, market reactions are often driven by guidance.
<h3>Historical Earnings Performance</h3>
The company's EPS missed by $0.21 in the last quarter, leading to a 2.21% increase in the share price on the following day.
Here's a look at Stepan's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.33</td>
<td>0.65</td>
<td>0.67</td>
<td>0.35</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.12</td>
<td>1.03</td>
<td>0.41</td>
<td>0.64</td>
</tr>
<tr>
<td>Price Change %</td>
<td>2.0%</td>
<td>-3.0%</td>
<td>-5.0%</td>
<td>1.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1745874081_0.png" alt="eps graph" />
<h3>Tracking Stepan's Stock Performance</h3>
Shares of Stepan were trading at $48.24 as of April 25. Over the last 52-week period, shares are down 41.93%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release. 
<a href="https://www.benzinga.com/quote/SCL/earnings">To track all earnings releases for Stepan visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: Stepan's Quarterly Earnings

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the <a href="https://www.benzinga.com/topic/rsi">RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">James Hardie Industries plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JHX#NYSE">JHX</a>)</h3>
<ul>
<li>On March 23, James Hardie Industries entered into an agreement to acquire The AZEK Company Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZEK#NYSE">AZEK</a>) in a transaction valued at $8.75 billion. The agreement will be structured with a combination of cash and shares of James Hardie, while also taking on AZEK's net debt of around $386 million. The company's stock fell around 23% over the past month and has a<a href="https://www.benzinga.com/quote/JHX"> 52-week low of $23.23</a>.</li>
<li>RSI Value: 25</li>
<li>JHX Price Action: Shares of James Hardie fell 1.6% to close at $24.25 on Friday.</li>
<li>Edge Stock Ratings: 12.01 Momentum score with Value at 58.52.</li>
</ul>
<h3 class="wp-block-heading">Minerals Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTX#NYSE">MTX</a>)</h3>
<ul>
<li>On March 5, Seaport Global analyst Michael Harrison maintained Minerals Technologies with a Buy rating and lowered the price target from $97 to $92. The company's stock fell around 7% over the past month and <a href="https://www.benzinga.com/quote/MTX">has a 52-week low </a> of $62.80.</li>
<li>RSI Value: 27</li>
<li>MTX Price Action: Shares of Minerals Technologies fell 2% to close at $63.61 on Friday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0331">MTX stock</a>. </li>
</ul>
<h3 class="wp-block-heading">Stepan Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>)</h3>
<ul>
<li>On Feb. 19, Stepan posted weaker-than-expected quarterly earnings. &#8220;While we are disappointed with our overall financial performance in 2024, we advanced our strategic investments and took necessary steps to return the Company to profitable growth.&nbsp; I am proud of the resilience, hard work and dedication of the entire organization.&nbsp; Full year Adjusted EBITDA grew 4% versus prior year despite several one-time events that negatively impacted earnings and the pre-operating expenses in our new Pasadena, site,&#8221; said Luis E. Rojo, President and Chief Executive Officer. The company's stock fell around 10% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/SCL">low of $54.89.</a></li>
<li>RSI Value: 28.9</li>
<li>SCL Price Action: Shares of Stepan fell 3.3% to close at $55.33 on Friday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0331">breakout in SCL shares</a>. </li>
</ul>
Read This Next:
<ul>
<li> <a href="https://www.benzinga.com/25/03/44534977/jim-cramer-healthpeak-properties-is-a-reasonable-reit-recommends-buying-this-health-care-stock">Jim Cramer: Healthpeak Properties Is A &#8216;Reasonable&#8217; REIT, Recommends Buying This Health Care Stock</a></li>
</ul>
Photo: Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

AZEK

Top 3 Materials Stocks That May Rocket Higher This Quarter

Stepan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.34 by 64.71 percent. This is a 63.64 percent decrease over earnings of $0.33 per share from the same period last year. The company reported quarterly sales of $525.61 million which beat the analyst consensus estimate of $522.30 million by 0.63 percent. This is a 1.23 percent decrease over sales of $532.13 million the same period last year.

Earnings Misses

Stepan Q4 Adj EPS $0.12 Misses $0.34 Estimate, Sales $525.61M Beat $522.30M Estimate

ACVA

AMPL

ANSS

APPN

BLCO

BMRN

BORR

CAKE

CCAP

CCSI

CHDN

CMTG

CVNA

CWAN

ENLT

ENVX

ETSY

EXAS

FOLD

First Trust Advantage Preferred Income Fund

FVRR

GLBE

GRAB

GRMN

ICLR

IIPR

IMAX

INSG

IONS

KALU

KPTI

KRYS

KVYO

LAND

LILA

LILAK

LOPE

LUNG

MANU

MATV

MGRC

MTRN

NDSN

NRDS

NYMT

OBDC

PAAS

PERI

PNST

PRAA

Earnings Scheduled For February 19, 2025

U.S. stock futures were slightly lower this morning, with the Dow futures falling around 0.1% on Tuesday.
Shares of Zeta Global Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) fell sharply in today's pre-market trading following <a href="https://www.benzinga.com/quote/ZETA/earnings">third-quarter results</a>.
Total revenue rose 42% year-over-year to $268.3 million, while the company posted GAAP loss per share of 9 cents versus a year-ago loss of 27 cents per share.
Zeta Global shares dipped 9.8% to $33.15 in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Destiny Tech100 Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXYZ#NYSE">DXYZ</a>) declined 21.3% to $33.40 in pre-market trading after gaining 17% on Monday.</li>
<li>Agora, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/API#NASDAQ">API</a>) fell 13.8% to $4.32 in pre-market trading. Agora will release its financial results for the third quarter ended Sept. 30 after the closing bell on Nov. 25.</li>
<li>Spirit Airlines, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SAVE#NYSE">SAVE</a>) shares declined 9.4% to $3.08 in pre-market trading after jumping over 25% on Monday.</li>
<li>Sangamo Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGMO#NASDAQ">SGMO</a>) fell 8.5% to $2.47 in pre-market trading.</li>
<li>Cipher Mining Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CIFR#NASDAQ">CIFR</a>) fell 7.4% to $6.88 in pre-market trading.</li>
<li>Ouster, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OUST#NYSE">OUST</a>) fell 7.2% to $9.79 in pre-market trading after jumping 32% on Monday.</li>
<li>Stepan Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) fell 5.5% to $75.14 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/41877638/jim-cramer-tech-stock-go-to-160-recommends-buying-dominos-pizza">Jim Cramer: This Tech Stock Can &#8216;Go To 160,&#8217; Recommends Buying Domino&#8217;s Pizza</a></li>
</ul>

Movers

CIFR

DXYZ

OUST

SAVE

SGMO

ZETA

Zeta Global, Spirit Airlines And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

&nbsp;Stepan Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) today reported:
&nbsp;
The Board of Directors of Stepan Company has approved an increase of $0.01 per share, or 2.7%, on the quarterly cash dividend on the Company's common stock. The dividend of $0.385 per share is payable on December 13, 2024, to common stockholders of record on November 29, 2024. The increase marks the 57th consecutive year in which the quarterly dividend on the Company's common stock has increased.

Dividends

Stepan Company Raises Quarterly Cash Dividend 2.7%, Now at $0.385 per Share

Stepan Q3 2024 Adj. EPS $1.03 Beats $0.65 Estimate, Sales $546.842M Miss $585.900M Estimate

Management

Stepan Announced The Appointment Of Luis E. Rojo As President And Chief Executive Officer And As A Member Of The Board Of Directors, Effective Immediately

U.S. stock futures were lower this morning, with the Dow futures falling over 150 points on Monday.
Shares of The Sherwin-Williams Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SHW#NYSE">SHW</a>) fell sharply in today's pre-market trading after Keybanc analyst Aleksey Yefremov downgraded the stock from <a href="https://www.benzinga.com/quote/SHW/analyst-ratings">Overweight to Sector Weight</a>.
Sherwin-Williams shares fell 1.4% to $366.00 in pre-market trading.
Here are some big stocks recording losses in today's pre-market trading session.
<ul>
<li>Chanson International Holding  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHSN#NASDAQ">CHSN</a>) shares declined 12.2% to $13.10 in pre-market trading after jumping 387% on Friday.</li>
<li>Heritage Insurance Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NASDAQ">HRTG</a>) shares dipped 6.9% to $11.35 in pre-market trading after gaining around 2% on Friday.</li>
<li>Sify Technologies Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SIFY#NASDAQ">SIFY</a>) shares fell 6.8% to $2.07 in pre-market trading after declining around 2% on Friday.</li>
<li>Stepan Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) shares fell 6.4% to $72.29 in pre-market trading after gaining 1% on Friday.</li>
<li>Mobileye Global Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBLY#NASDAQ">MBLY</a>) shares fell 4.9% to $12.30 in pre-market trading after climbing over 4% on Friday.</li>
<li>Evotec SE  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVO#NYSE">EVO</a>) shares declined 3.5% to $3.31 in pre-market trading after gaining 2% on Friday.</li>
<li>Apple Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>) shares fell 1.3% to $223.86 in pre-market trading.</li>
</ul>
Now Read This:<a href="https://www.benzinga.com/markets/24/10/41194621/top-3-risk-off-stocks-that-may-explode-this-month"> </a>
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41194621/top-3-risk-off-stocks-that-may-explode-this-month">Top 3 Risk Off Stocks That May Explode This Month</a></li>
</ul>

AAPL

CHSN

HRTG

MBLY

SIFY

Sherwin-Williams, Apple And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Shares of Arcadium Lithium plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTM#NASDAQ">ALTM</a>) rose sharply in today's pre-market trading after the company confirmed non-binding acquisition <a href="https://www.benzinga.com/quote/ALTM/analyst-ratings">approach by Rio Tinto</a>.
Arcadium Lithium shares jumped 27.8% to $3.94 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul>
<li>LogicMark, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGMK#NASDAQ">LGMK</a>) rose 54.5% to $0.1735 in pre-market trading after dipping 17% on Friday.</li>
<li>TDH Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PETZ#NASDAQ">PETZ</a>) rose 36.2% to $1.84 in pre-market trading after jumping 13% on Friday.</li>
<li>Top Wealth Group Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TWG#NASDAQ">TWG</a>) gained 16.8% to $1.95 in pre-market trading after declining 5% on Friday.</li>
<li>UP Fintech Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) shares gained 13.3% to $14.04 in pre-market trading after jumping around 35% on Friday.</li>
<li>Garden Stage Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSIW#NASDAQ">GSIW</a>) shares rose 13.1% to $2.16 in pre-market trading after gaining around 3% on Friday.</li>
<li>1847 Holdings LLC (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EFSH#NYSE">EFSH</a>) shares surged 12.6% to $1.25 in pre-market trading after dipping 17% on Friday.</li>
<li>QuantaSing Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QSG#NASDAQ">QSG</a>) shares jumped 11% to $4.13 in pre-market trading after gaining 17% on Friday.</li>
<li>The Duckhorn Portfolio, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NAPA#NYSE">NAPA</a>) shares gained 11% to $6.00 in pre-market trading ahead of quarterly earnings.</li>
<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) gained 9.5% to $0.5035 in pre-market trading after dipping around 12% on Friday.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul>
<li>Trevena, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRVN#NASDAQ">TRVN</a>) shares dipped 39% to $2.81 in pre-market trading after the company announced it received a Nasdaq delisting notification.</li>
<li>Beneficient (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BENF#NASDAQ">BENF</a>) fell 22.2% to $1.47 in today's pre-market trading. Beneficient shares jumped around 59% on Friday after the company announced its subsidiary, Beneficient Company Holdings, consummated a previously announced transaction pursuant to which approximately $126 million of its preferred equity was redesignated as non-redeemable.</li>
<li>Mynaric AG (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYNA#NASDAQ">MYNA</a>) shares fell 18.7% to $1.26 in pre-market trading after gaining 4% on Friday.</li>
<li>Cemtrex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) fell 18.4% to $1.64 in pre-market trading after declining 21% on Friday.</li>
<li>Cheetah Net Supply Chain Service Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) declined 17.2% to $0.2330 in pre-market trading after dipping around 24% on Friday.</li>
<li>Vicinity Motor Corp.  (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VEV#NASDAQ">VEV</a>) shares declined 17.3% to $0.1448 in pre-market trading after gaining around 23% on Friday.</li>
<li>DigiAsia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FAAS#NASDAQ">FAAS</a>) fell 15.8% to $1.75 in pre-market trading after declining 8% on Friday.</li>
<li>Chanson International Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHSN#NASDAQ">CHSN</a>) shares fell 15.8% to $12.47 in pre-market trading after jumping 387% on Friday.</li>
<li>Stepan Company  (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) shares fell 6.5% to $72.29.</li>
<li>Fortuna Mining Corp. NYSE: FSM) shares declined 5.3% to $4.62 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/10/41196046/wall-streets-most-accurate-analysts-give-their-take-on-3-energy-stocks-delivering-high-dividend-yiel">Wall Street&#8217;s Most Accurate Analysts Give Their Take On 3 Energy Stocks Delivering High-Dividend Yields</a></li>
</ul>

ALTM

BENF

BLRX

CETX

CTNT

EFSH

FAAS

GSIW

LGMK

MYNA

NAPA

PETZ

TIGR

TRVN

Why Arcadium Lithium Shares Are Trading Higher By 28%; Here Are 20 Stocks Moving Premarket

The most oversold stocks in the materials sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the R<a href="https://www.benzinga.com/topic/rsi">SI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Ingevity Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NGVT#NYSE">NGVT</a>)</h3>
<ul>
<li>On July 31, Ingevity posted weaker-than-expected quarterly results. &#8220;As we move forward with transforming Performance Chemicals into a more profitable and stable segment, we continue to see Performance Materials deliver best-in-class results,&#8221; said John Fortson, president and CEO. The company's stock fell around 22% over the past five days and has a <a href="https://www.benzinga.com/quote/NGVT">52-week low of $34.37</a>.</li>
<li>RSI Value: 18.64</li>
<li>NGVT Price Action: Shares of Ingevity fell 14.1% to close at $35.41 on Monday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to l<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1">atest NGVT news</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="907" height="818" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034750/image-17.png" alt="" class="wp-image-478138" style="width:408px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034750/image-17.png 907w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034750/image-17-300x271.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034750/image-17-768x693.png 768w" sizes="(max-width: 907px) 100vw, 907px" /></a></figure>
<h3 class="wp-block-heading">Posco Holdings Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PKX#NYSE">PKX</a>)&nbsp;</h3>
<ul>
<li>The company's stock fell around 10% over the past five days. It <a href="https://www.benzinga.com/quote/PKX">has a 52-week low</a> of $58.00.</li>
<li>RSI Value: 19.33</li>
<li>PKX Price Action: Shares of Posco fell 9.2% to close at $58.66 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1"> trend in PKX stock</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="912" height="827" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034854/image-18.png" alt="" class="wp-image-478140" style="width:541px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034854/image-18.png 912w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034854/image-18-300x272.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06034854/image-18-768x696.png 768w" sizes="(max-width: 912px) 100vw, 912px" /></a></figure>
<h3 class="wp-block-heading">Mp Materials Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MP#NYSE">MP</a>)</h3>
<ul>
<li>On Aug. 1, MP Materials reported worse-than-expected second-quarter financial results. &#8220;We had a very challenging quarter, operationally and financially, with higher-than-expected upstream downtime and a continued weak pricing environment. Despite this, we more than doubled NdPr production sequentially. We also signed a substantial new NdPr supply agreement with a global automaker,&#8221; said James Litinsky, Founder, Chairman and CEO of MP Materials. The company's shares fell around 21% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/MP">low of $10.02</a>.</li>
<li>RSI Value: 20.10</li>
<li>MP Price Action: Shares of Mp Materials fell 5.8% to close at $10.52 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1"> breakout in MP shares</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="887" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035005/image-1-10.png" alt="" class="wp-image-478145" style="width:519px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035005/image-1-10.png 887w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035005/image-1-10-300x282.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035005/image-1-10-768x723.png 768w" sizes="(max-width: 887px) 100vw, 887px" /></a></figure>
<h3 class="wp-block-heading">Stepan Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>)</h3>
<ul>
<li>On July 31, Stepan reported worse-than-expected second-quarter financial results. &#8220;Second quarter earnings were significantly impacted by higher operational expenses at our Millsdale site, start up costs related to our new Pasadena investment and a criminal social engineering event that targeted one of our Asia subsidiaries, leading to unexpected expense in the quarter.&nbsp; We are actively investigating this fraud event with the assistance of outside counsel, and to date, we have not found any evidence of additional fraudulent activity,&#8221; said Scott Behrens, President and Chief Executive Officer. The company's shares lost around 18% over the past five days. The company's 52-week low is $63.60.</li>
<li>RSI Value: 19.84</li>
<li>SCL Price Action: Shares of Stepan fell 6.5% to close at $73.00 on Monday.</li>
<li>Benzinga Pro&#8217;s earnings calendar was used to t<a href="https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1">rack earnings reports of SCL</a>.</li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/?utm_source=BZprocontent080624&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="890" height="835" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035227/image-19.png" alt="" class="wp-image-478150" style="width:503px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035227/image-19.png 890w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035227/image-19-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/08/06035227/image-19-768x721.png 768w" sizes="(max-width: 890px) 100vw, 890px" /></a></figure>
Read More: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/08/40178833/dow-records-worst-day-in-around-2-years-mag-7-stocks-lose-650b-in-market-capitalization-greed-index">Dow Records Worst Day In Around 2 Years, Mag 7 Stocks Lose $650B In Market Capitalization: Greed Index Moves To &#8216;Extreme Fear&#8217; Zone</a></li>
</ul>

NGVT

Top 4 Materials Stocks Which Could Rescue Your Portfolio This Month

WIIM

Stepan shares are trading lower after the company reported worse-than-expected Q2 financial results.

Guidance

Stepan Expects Second Half EBITDA To Improve Versus Prior Year; Says Positioned To Deliver Full Year Adjusted EBITDA Growth And Positive Free Cash Flow

Stepan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) reported quarterly earnings of $0.41 per share which missed the analyst consensus estimate of $0.67 by 38.81 percent. The company reported quarterly sales of $556.405 million which missed the analyst consensus estimate of $589.800 million by 5.66 percent. This is a 4.06 percent decrease over sales of $579.975 million the same period last year.

Stepan Q2 2024 Adj. EPS $0.41 Misses $0.67 Estimate, Sales $556.405M Miss $589.800M Estimate

F. Quinn Stepan, Jr., Board Member at Stepan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>), reported an insider buy on May 14, according to a new SEC filing. 
What Happened: Jr. made a significant move by purchasing 1,396 shares of Stepan as reported in a Form 4 filing with the <a href="https://www.sec.gov/Archives/edgar/data/0000094049/000112760224015324//Archives/edgar/data/94049/000112760224015324/0001127602-24-015324-index.htm">U.S. Securities and Exchange Commission</a>. The transaction's total worth stands at $124,983.
Stepan's shares are actively trading at $87.89, experiencing a down of 0.0% during Wednesday's morning session.
<h3>Delving into Stepan's Background</h3>
Stepan Co manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on product type. The surfactants segment, which generates the majority of revenue, sells cleaning agents used in detergents, shampoos, body wash, fabric softeners, toothpastes, and other personal-care products. Surfactants are chemical agents that affect the interaction between two surfaces. The polymers segment sells polyurethane used to manufacture rigid foam for thermal insulation, as well as phthalic anhydride used to make plastic components for the construction, automotive, and boating industries. The specialty products segment sells chemicals used in food and flavoring. Majority of Stepan's revenue comes from the United States.
<h3>Breaking Down Stepan's Financial Performance</h3>
Decline in Revenue: Over the 3 months period, Stepan faced challenges, resulting in a decline of approximately -15.35% in revenue growth as of 31 March, 2024. This signifies a reduction in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Materials sector.
Evaluating Earnings Performance:
<ul>
<li>
Gross Margin: The company faces challenges with a low gross margin of 12.75%, suggesting potential difficulties in cost control and profitability compared to its peers.
</li>
<li>
Earnings per Share (EPS): Stepan's EPS is below the industry average, signaling challenges in bottom-line performance with a current EPS of 0.61.
</li>
</ul>
Debt Management: With a below-average debt-to-equity ratio of 0.58, Stepan adopts a prudent financial strategy, indicating a balanced approach to debt management.
Market Valuation:
<ul>
<li>
Price to Earnings (P/E) Ratio: Stepan's stock is currently priced at a premium level, as reflected in the higher-than-average P/E ratio of 52.95.
</li>
<li>
Price to Sales (P/S) Ratio: With a lower-than-average P/S ratio of 0.91, the stock presents an attractive valuation, potentially signaling a buying opportunity for investors interested in sales performance.
</li>
<li>
EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation &amp; Amortization): At 14.97, Stepan's EV/EBITDA ratio reflects a below-par valuation compared to industry averages signalling undervaluation
</li>
</ul>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
<a href="https://www.schwab.com/brokerage?aff=XEC">Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.</a>
<h3>Uncovering the Importance of Insider Activity</h3>
It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.
In the realm of legality, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities under Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are required to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.
Notably, when a company insider makes a new purchase, it is considered an indicator of their positive expectations for the stock.
Conversely, insider sells may not necessarily signal a bearish stance on the stock and can be motivated by various factors.
<h3>Navigating the World of Insider Transaction Codes</h3>
Examining transactions, <a href="https://www.benzinga.com/money/investing-tools">investors</a> often concentrate on those unfolding in the open market, meticulously detailed in Table I of the Form 4 filing. A P in Box 3 denotes a purchase, while S signifies a sale. Transaction code C indicates the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.
<a href="https://www.benzinga.com/sec/insider-trades/search/index?company_cik=0000094049">Check Out The Full List Of Stepan's Insider Trades.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insider Trades

Insider Move: F. Quinn Stepan, Jr. Invests $124K In Stepan Stock

&quot;Looking forward, we believe sales volumes will continue to gradually improve due to ongoing recovery in Rigid Polyols and growth in Surfactant volumes including the expected recovery of the Agricultural business in the second half of the year,&quot; said&nbsp;Scott Behrens, President and Chief Executive Officer.&nbsp;

Stepan Expects To Deliver Full Year Adjusted EBITDA Growth And Positive Free Cash Flow

Stepan Says On Track To Deliver Its $50M Cost Out Goal For 2024 And Recognized $18M In Pre-tax Savings In Q1

Stepan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCL#NYSE">SCL</a>) reported quarterly Adj earnings of $0.64 per share which beat the analyst consensus estimate of $0.35 by 82.86 percent. This is a 9.86 percent decrease over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $551.418 million which missed the analyst consensus estimate of $575.825 million by 4.24 percent. This is a 15.35 percent decrease over sales of $651.436 million the same period last year.

Stepan Q1 2024 Adj EPS $0.64 Beats $0.35 Estimate, Sales $551.418M Miss $575.825M Estimate

Commodities

Press Releases

Stepan Promotes Luis E. Rojo to President and Chief Executive Officer

Stepan Reports Third Quarter 2024 Results

Stepan Increases Quarterly Cash Dividend, Marking the 57th Consecutive Year of Increases

Stepan to Announce Fourth Quarter and Full Year 2024 Results on February 19, 2025

Comments

Stepan

ニュース

最新ニュース Stepan (NYSE:SCL) 株価情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル